Tadalafil reduces airway hyperactivity and protects against lung and respiratory airways dysfunction in a rat model of silicosis
Authors:
- 1 November 2016
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 40, 530-541
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Tranilast ameliorates cyclophosphamide-induced lung injury and nephrotoxicityCanadian Journal of Physiology and Pharmacology, 2016
- Modulation of thioacetamide-induced liver fibrosis/cirrhosis by sildenafil treatmentCanadian Journal of Physiology and Pharmacology, 2013
- IL-13 Immunotoxin Accelerates Resolution of Lung Pathological Changes Triggered by Silica Particles in MiceThe Journal of Immunology, 2013
- Tadalafil for the Treatment of Pulmonary Arterial HypertensionJACC, 2012
- The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in ratsMolecular Biology Reports, 2012
- Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetaseNature Chemical Biology, 2012
- Efficacy of tadalafil in chronic hypobaric hypoxia–induced pulmonary hypertension: possible mechanismsFundamental & Clinical Pharmacology, 2012
- A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in ratsPulmonary Pharmacology & Therapeutics, 2008
- Silica binding and toxicity in alveolar macrophagesFree Radical Biology and Medicine, 2008
- Silicosis in 76 Men: Qualitative and Quantitative CT Evaluation—Clinical-Radiologic Correlation StudyRadiology, 2003